Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Countries

 

Optegra sale on hold

HBI understands from multiple sources that the sale of UK-based ophthalmology group Optegra is on hold.
November 22, 2022

Is Orpea’s bold plan enough to save the business?

Plagued with well documented allegations and investigations, and saddled with €9bn+ debt, on Tuesday Orpea presented its plan for recovery to the creditors who last month gave it just four months to clean up its finances. Has it done enough? We speak to a range of market experts to find out if it can weather the storm. 
November 18, 2022

The current state of interest and inflation rates

The current macroeconomic environment is slowing down health care services M&A, as inflation eats into margins and debt financing dries up. In this week's infographic we look at the state of interest rates and inflation rates in major economies across the world.
November 18, 2022

FREE BLOG Going somewhere new? Go digital

There's an air of confusion around digitalisation / telehealth. Everyone knows it is important. But as a standalone prospect, it takes time to make a profit. Babylon's stock crash, and Kry's withdrawal from Germany and continuing layoffs do little to dispel digital doom, and many patients insist on a hybrid model of care. But for healthcare companies looking to expand to pastures new, going digital can offer a cheap way to test the water.
November 18, 2022

Scottish dental group “up for sale”

HBI hears that Scottish dental group Clyde Munro is about to go up for sale, and speaks to an operator and an investor source to find out more.
November 18, 2022

Medanta’s parent IPOs

Global Health Ltd, the parent company of Indian hospital chain Medanta, closed subscription for its IPO on Monday, with a valuation of 22,060m rupees ($274m). The share price has been set at 319 Rs ($3.96). The IPO will consist of new shares worth 5,000m Rs ($62m), and an offer-for-sale of up to 50.8m Rs ($0.63m) worth of shares.
November 11, 2022

Interview: Lars Dahle, founder, Dignio

Having spent the last 10 years of his life building a multi-million revenue company, Dignio founder Lars Dahle has found the last week since he stepped down as CEO rather quiet. HBI catches up with him in reflective mood, as he chats about how he built the business up, and how he really feels about leaving his company's future in others' hands.
November 10, 2022

Deals postponed and at risk

Deal flow is slowing rapidly. HBI hears CVC has postponed the sale of Finland-based occupational and outpatient specialist Mehilainen. The Trilantic sale of Berlin-based mental health specialist Oberberg, and the Nordic sale of European Dental Group are both at risk too. But we hear that the sales of ophtha group Optegra and diagnostic group Rad-X are likely to proceed.
November 4, 2022
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us